Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study-Reference-Cited by-同舟云学术

Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study

Published:2021-06 Issue:6 Volume:18 Page:977-986
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Waks Jonathan W.,Haq Kazi T.,Tompkins Christine,Rogers Albert J.,Ehdaie Ashkan,Bender Aron,Minnier Jessica,Dalouk Khidir,Howell Stacey,Peiris Achille,Raitt Merritt,Narayan Sanjiv M.,Chugh Sumeet S.,Tereshchenko Larisa G.

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

American Heart Association

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference23 articles.

1. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary

2. Defibrillator implantation in patients with nonischemic systolic heart failure;Kober;N Engl J Med,2016

3. Global electric heterogeneity risk score for prediction of sudden cardiac death in the general population: the Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies;Waks;Circulation,2016